Ditchcarbon
  • Customers
  1. Organizations
  2. Mckesson
Public Profile
Pharmaceutical Preparation Manufacturing
CA
updated 4 days ago

Mckesson

Company website

McKesson Corporation, a leading player in the healthcare industry, is headquartered in California and operates extensively across North America. Founded in 1833, McKesson has evolved into a vital partner for healthcare providers, offering a comprehensive range of services including pharmaceutical distribution, healthcare management solutions, and technology integration. The company is renowned for its innovative approach to supply chain management and its commitment to improving patient care through advanced data analytics and pharmacy services. With a strong market position, McKesson consistently ranks among the top companies in the Fortune 500, reflecting its significant impact on the healthcare landscape. Its dedication to enhancing operational efficiency and patient outcomes sets McKesson apart as a trusted leader in the industry.

DitchCarbon Score

How does Mckesson's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

55

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Mckesson's score of 55 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.

74%

Let us know if this data was useful to you

Mckesson's reported carbon emissions

In 2024, McKesson Corporation reported total greenhouse gas emissions of approximately 32,569,160,000 kg CO2e across all scopes. This includes about 79,848,000 kg CO2e from Scope 1 emissions and approximately 152,129,000 kg CO2e from Scope 2 emissions (market-based). The majority of their emissions, about 32,569,160,000 kg CO2e, stem from Scope 3, which encompasses indirect emissions from the value chain. McKesson has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 50.4% by FY2032, using FY2020 as the baseline year. Additionally, the company plans for 70% of its suppliers, by spend on purchased goods and services, to have science-based targets by FY2027. These targets align with the Science Based Targets initiative (SBTi) and are designed to contribute to limiting global warming to 1.5°C. In 2023, McKesson's emissions were reported at approximately 28,980,752,000 kg CO2e, indicating a significant focus on tracking and managing their carbon footprint. The company continues to disclose emissions data across all three scopes, demonstrating transparency and commitment to sustainability in the pharmaceutical sector.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20162017201820202021202220232024
Scope 1
92,194,000
00,000,000
000,000,000
00,000,000
000,000,000
00,000,000
00,000,000
00,000,000
Scope 2
188,912,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
28,733,000
00,000,000
00,000,000
00,000,000,000
00,000,000,000
00,000,000,000
00,000,000,000
00,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Mckesson's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Mckesson is in CA, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Mckesson is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Abbott

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 3 days ago

Entero Healthcare Solutions Limited

IN
•
Health and social work services (85)
Updated 3 days ago

Omron

JP
•
Electrical machinery and apparatus n.e.c. (31)
Updated 3 days ago

Ibm

US
•
Computer and related services (72)
Updated about 8 hours ago

AmerisourceBergen Drug Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Procter And Gamble

US
•
Chemicals nec
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250731.5
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy